Genetic Assessment of the Patients With Metabolic Syndrome
NCT ID: NCT01268696
Last Updated: 2011-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2010-12-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of Genetic Risk of Cardiovascular Disease in Prospective Cohort Study
NCT00262691
Genomewide Search for Loci Underlying Metabolic Syndrome
NCT00074451
Impact of the Genetic Background as a Risk Factor for Atherosclerotic Cardiovascular Disease in the Brazilian Population
NCT05515653
Genetic Epidemiology of CVD Risk Factors
NCT00053521
Genetics of Cardiovascular Disease
NCT06253481
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* patients with metabolic syndrome
* with written consent
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
healthy volunteers
No interventions assigned to this group
Metabolic group
Patients with metabolic syndrome
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* cancer
* not consent
* steroid therapy
* alcohol or drug abuse
* chronic inflammatory disease
* pregnancy or lactation
* severe hypothyroidism
* immunosuppressive treatment
* operation or severe injury during the last month
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Lodz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Medical University of Lodz
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tadeusz Pietrucha, prof.
Role: STUDY_CHAIR
Department of medical biotechnology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of medical biotechnology Medical University of Lodz
Lodz, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RNN/202/10/KE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.